Clinicopathological profile and operative outcomes of gastric cancer patients in Kashmir: a high incidence area

Mohamad Younis; Arshid Iqbal Qadri; Ajay Vane; Adfar Yousuf; Mudasir Hamid Bhat

doi:10.18203/2320-6012.ijrms20220389

Authors

Mohamad Younis Department of Surgical Gastroenterology, SKIMS, Soura Srinagar, Jammu and Kashmir, India
Arshid Iqbal Qadri Department of General and Minimal Access Surgery, SMHS, Srinagar, Jammu and Kashmir, India
Ajay Vane Department of Surgical Gastroenterology, SKIMS, Soura Srinagar, Jammu and Kashmir, India
Adfar Yousuf Sri Pratap College, Cluster University, Srinagar, Kashmir, India
Mudasir Hamid Bhat Department of Radiodiagnosis, SKIMS, Soura Srinagar, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20220389

Keywords:

Gastric cancer, Kashmir, Gastrectomy, Outcome, SKIMS, D2, Lymphadenectomy

Abstract

Background: The objective of the present study was to analyse the demographic, clinicopathological and perioperative outcome of patients undergoing D2 gastrectomy in a high-volume tertiary care hospital in Kashmir a high incidence area.

Methods: A total of 89 gastric cancer patients operated in the department of surgical gastroenterology, SKIMS, Kashmir, from January 2018 to December 2021 were included. A standardized D2 lymphadenectomy with spleen/pancreas preservation was performed.

Results: Most of the patients in our study were elderly males and the mean age of patients in our series was 60.12±9.4. Majority of the patients in this study had stage III (91%) disease. Nodal involvement (N2, N3) was seen in 66% of patients. The average blood loss during operation was (380.23±48.53 ml) in our patients. The mean number of harvested lymph nodes was (26.6±10.1) with the range of (12-40). Mean operative time was (180±32.58 min). Average hospital stay was (8±2.46 days) in this series.

Conclusions: Data from our study suggests that D2-gastrectomy when performed by skilled team in high volume centre like SKIMS is safe and should be the standard of care for gastric cancer for improved outcome.

Metrics

Metrics Loading ...

Author Biography

Mohamad Younis, Department of Surgical Gastroenterology, SKIMS, Soura Srinagar, Jammu and Kashmir, India

Assistant Professor Department of Surgical Gastroenterology , Sher-i-Kashmir Institute of Medical Sciences , Soura Srinagar , Kashmir India 190011.

References

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Cancer J Clin. 2011;61(2):69-90.

Globocon 2012 (IARC). Stomach cancer estimated incidence, mortality and prevalence worldwide. 2012.

Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9-29.

Indian Council of Medical Research. Consensus document for management of gastric cancer. 2014.

Rasool MT, Lone MM, Wani ML, Afroz F, Zaffar S, Haq MM. Cancer in Kashmir, India: burden and pattern of disease. J Canc Res Therapeut. 2012;8(2):243-6.

Khan NA, Ahmad SN, Masoodi SR, Maqbool M. Changing pattern of common cancers in the last five years in Kashmir, India: a retrospective observational study. Indian J Med Paediatr Oncol. 2021;42(5):439-43.

Shrikhande SV, Barreto SG, Talole SD, Vinchurkar K, Annaiah S, Suradkar K, et al. D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy. World J Surg Oncol. 2013;2:11-31.

Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345(8952):745-8.

Lam S, Tan E, Menezes A, Martin D, Gallagher J, Storey D, et al. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching. World J Surg Oncol. 2018;16(1):136.

Kavaliauskas P, Maziukas R, Samalavicius NE, Kuliavas J, Lunevicius R. Subtotal gastrectomy with conventional D2 lymphadenectomy for carcinoma of the distal gastric portion: a retrospective cohort study on clinical outcome. Ann Med Surg (Lond). 2016;6:36-41.

Roviello F, Marrelli D, Morgagni P, Manzoni G, Leo A, Vindigni C, et al. Survival benefit of extendedD2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol. 2002;9(9):894-900.

Biffi R, Chiappa A, Luca F, Pozzi S, Faso FL, Cenciarelli S, et al Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single centreseries of 250 patients. J Surg Oncol. 2006;93(5):394-400.

Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725-30.

Wanebo HJ, Kennedy BJ, Winchester DP, Fremgen A, Stewart AK. Gastric carcinoma: does lymph node dissection alter survival? J Am Coll Surg. 1996;183(6):616-24.

Coburn NG, Swallow CJ, Kiss A, Law C. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer. 2006;107(9):2143-51.

Datta J, Lewis RS, Mamtani R, Stripp D, Kelz RR, Drebin JA, et al. Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base. Cancer. 2014;120(12):2855-65.

Bouvier A, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J. How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer. 2002;94(11):2862-6.

Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg. 2000;232(3):362-71.

Woo Y, Goldner B, Ituarte P, Lee B, Melstrom L, Son T, et al. Lymphadenectomy with optimum of 29 lymph nodes retrieved associated with improved survival in advanced gastric cancer: a 25,000-patient international database study. J Am Coll Surg. 2017;224(4):546-55.

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. Stomach. AJCC Cancer Staging Manual. 8th ed. Chicago: AJCC; 2017: 203.

Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, et al Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The surgical cooperative group. Lancet. 1996;347(9007):995-9.

Hartgrink HH, Velde CJ, Putter H, Bonenkamp JJ, Kranenbarg E, Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22(11):2069-77.

Songun I, Putter H, Kranenbarg EM, Sasako M, Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439-49.

Mahar AL, McLeod RS, Kiss A, Paszat L, Coburn NG. A systematic review of the effect of institution and surgeon factors on surgical outcomes for gastric cancer. J Am Coll Surg. 2012;214:860.

Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1-19.

Zhu AL, Sonnenberg A. Is gastric cancer again rising? J Clin Gastroenterol. 2012;46(9):804-6.

Correa P. Gastric cancer: two epidemics? Dig Dis Sci. 2011;56(5):1585-6.

Safaee A, Moghimi-Dehkordi B, Fatemi SR, Safaee A, Moghimi-Dehkordi B, Fatemi S, et al. Clinicopathological features of gastric cancer: a study based on cancer registry data. IJCP. 2009;2(6):67-70.

Sasagawa T, Solano H, Mena F. Gastric cancer in Costa Rica. Gastrointest Endosc. 1999;50(4):594-5.

Yao JC, Tsen JF, Worah S, Hess KR, Mansfield PF, Crane CH. Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution’s experience over 15 years. J Clin Oncol. 2005;23(13):3094-103.

Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer. 2003;107(1):113-8.

Nandi A, Biswas PK, Kar M, Sinha SK. Clinicopathological profile of gastric cancer in a tertiary care hospital in Eastern India: a prospective 2 year study. Clin Cancer Investig J. 2014;3(1):14-20.

Zheng L, Wu C, Xi P, Zhu M, Zhang L, Chen S, et al. The survival and the long-term trends of patients with gastric cancer in Shanghai, China. BMC Cancer. 2014;14:300.

Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88(4):921-32.

Mickevicius A, Ignatavicius P, Markelis R, Parseliunas A, Butkute D, Kiudelis M, et al. Trends and results in treatment of gastric cancer over last two decades at single East European centre: a COHORT study. BMC Surg. 2014;14:98.

Bhandare MS, Kumar NAN, Batra S, Shrikhande SV. Radical gastrectomy for gastric cancer at Tata Memorial Hospital. Indian J Cancer. 2017;54(4):605-8.

Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, et al. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg. 2006;23(3):192-7.

Malik GM, Mubarik M, Kadla SA, Durrani HA. Gastric cancer profile in Kashmiri population with special dietary habits. Diagn Ther Endosc. 2000;6(2):83-6.